Health & Personal Care
HIGH
FDA DRUG
Merck Recalls Belsomra Tablets Due to Dissolution Issues
Merck Sharp & Dohme LLC recalled 51,320 cartons of Belsomra (suvorexant) tablets on July 21, 2025. The recall stems from a failure in dissolution specifications that could delay drug release. Consumers should stop using the product immediately and consult healthcare providers for guidance.
BELSOMRA
Failed Dissolution